Psychedelics Services

Here's What You Need To Know

With an evolving regulatory landscape and increasing investment into the market, psychedelics, as a subject for research and clinical trials, is primed to be a major emerging industry in Canada. Companies looking to enter this burgeoning psychedelics market can count on dicentra Cannabis & Psychedelics Consulting to help them navigate the regulatory landscape for controlled substances related to psilocybin.

Our Services Include Consulting Support With The Following:

  • Filing for an exemption under Section 56(1) of the Controlled Drugs and Substances Act for physicians and researchers
  • Filing an application for a Controlled Drugs and Substances Dealer’s Licence
  • Obtaining a permit for both import and export of Controlled Substances from Health Canada
  • Obtaining an authorization to purchase a restricted drug from a licenced dealer for clinical trials
  • Obtaining an authorization for the sale of a restricted drug by a licenced dealer